• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.63 Down 0.02(3.08%) 4:02PM EST
    Add to Portfolio
    Prev Close:0.65
    Open:0.67
    Bid:0.54 x 500
    Ask:0.85 x 100
    1y Target Est:1.45
    Beta:0.38
    Next Earnings Date:N/A
    Day's Range:0.63 - 0.67
    52wk Range:0.53 - 1.47
    Volume:118,655
    Avg Vol (3m):133,564
    Market Cap:32.52M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBY

    Comparison

    Symbol% ChgMkt Cap
    NBYDown 3.08%32.52M
    ABTUp 3.41%68.92B
    PFEUp 2.73%201.43B
    SNNUp 3.70%15.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.30
    Quarterly EPS Est (Dec-14) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback